NCEL
Price:
$2.55
Market Cap:
$1.15M
NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland.
Industry
Biotechnology
IPO Date
2025-10-24
Stock Exchange
NASDAQ
Ticker
NCEL
According to NewcelX Ltd.’s latest financial reports and current stock price. The company's current ROE is -100.99%. This represents a change of 690.37% compared to the average of -12.78% of the last 4 quarters.
The mean historical ROE of NewcelX Ltd. over the last ten years is -312.74%. The current -100.99% ROE has changed -67.71% with respect to the historical average. Over the past ten years (40 quarters), NCEL's ROE was at its highest in in the June 2022 quarter at 213.80%. The ROE was at its lowest in in the December 2021 quarter at -1353.78%.
Average
-312.74%
Median
15.95%
Minimum
-2202.50%
Maximum
137.79%
Discovering the peaks and valleys of NewcelX Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 151.06%
Maximum Annual ROE = 137.79%
Minimum Annual Increase = -7015.19%
Minimum Annual ROE = -2202.50%
| Year | ROE | Change |
|---|---|---|
| 2024 | -140.85% | -202.22% |
| 2023 | 137.79% | -127.41% |
| 2022 | -502.79% | -77.17% |
| 2021 | -2202.50% | -7015.19% |
| 2020 | 31.85% | -63.92% |
| 2019 | 88.27% | 151.06% |
| 2018 | 0.06% | -99.93% |
The current ROE of NewcelX Ltd. (NCEL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-168.61%
5-year avg
-535.30%
10-year avg
-312.74%
NewcelX Ltd.’s ROE is less than Ocean Biomedical, Inc. (14.04%), less than IMAC Holdings, Inc. (162.69%), greater than Prenetics Global Limited (-28.93%), greater than Surrozen, Inc. (-4404.21%), less than CERo Therapeutics Holdings, Inc. (989.65%), greater than SAB Biotherapeutics, Inc. (-38.08%), greater than BriaCell Therapeutics Corp. (-306.72%), greater than Nuwellis, Inc. (-1308.35%), less than Celularity Inc. (763.31%), greater than Pasithea Therapeutics Corp. (-97.88%),
| Company | ROE | Market cap |
|---|---|---|
| 14.04% | $652.49K | |
| 162.69% | $302.80K | |
| -28.93% | $271.19M | |
| -4404.21% | $189.26M | |
| 989.65% | $60.27K | |
| -38.08% | $42.25M | |
| -306.72% | $20.16K | |
| -1308.35% | $3.78M | |
| 763.31% | $30.48M | |
| -97.88% | $6.40M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NewcelX Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NewcelX Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is NewcelX Ltd.'s ROE?
How is the ROE calculated for NewcelX Ltd. (NCEL)?
What is the highest ROE for NewcelX Ltd. (NCEL)?
What is the 3-year average ROE for NewcelX Ltd. (NCEL)?
What is the 5-year average ROE for NewcelX Ltd. (NCEL)?
How does the current ROE for NewcelX Ltd. (NCEL) compare to its historical average?